|国家科技期刊平台
首页|期刊导航|中国脑血管病杂志|心房颤动相关心源性脑梗死再灌注治疗临床结局的影响因素分析

心房颤动相关心源性脑梗死再灌注治疗临床结局的影响因素分析OACSTPCD

Analysis of clinical outcomes after reperfusion therapy for atrial fibrillation-related cardiogenic cerebral infarction

中文摘要英文摘要

目的 分析心房颤动相关心源性脑梗死再灌注治疗临床结局不良的影响因素.方法 回顾性连续纳入2018 年9 月至2020 年9 月苏州大学附属第一医院和江阴市人民医院卒中中心心房颤动相关心源性脑梗死再灌注治疗(包括单纯静脉溶栓、机械取栓和桥接治疗)患者.详细收集患者资料,包括性别、年龄、既往史(高血压病、糖尿病、高脂血症、缺血性卒中、冠心病、慢性心力衰竭、吸烟史);收集入院检查指标[首次发现异常至急诊时间、收缩压、舒张压、美国国立卫生研究院卒中量表(NIHSS)评分]及治疗前实验室检查结果[随机血糖、D-二聚体、超敏C反应蛋白、N末端B型利钠肽原(NT-proBNP)、纤维蛋白原];根据患者头颈部CT血管成像+CT灌注成像区分责任血管所在部位(前循环、后循环、前后循环)并收集相关影像学参数(梗死核心体积和缺血半暗带体积).单纯静脉溶栓和桥接治疗患者收集入院至静脉溶栓时间,机械取栓和桥接治疗患者收集入院至动脉穿刺时间及取栓后血管再通情况[改良脑梗死溶栓(mTICI)分级].收集患者出院时情况(出院NIHSS评分).根据出院后90d随访mRS评分将患者分为结局不良(mRS评分3~6 分)组和结局良好(mRS评分0~2 分)组,比较两组患者基线资料,通过多因素Logistic回归分析方法分析影响心房颤动相关心源性脑梗死再灌注治疗临床结局的因素,并分别生成受试者工作特征(ROC)曲线,计算曲线下面积,探讨对结局不良的预测价值.结果 共纳入心房颤动相关心源性脑梗死再灌注治疗患者152 例,男86 例,女66 例;年龄38~91 岁,平均(73±10)岁.其中单纯静脉溶栓52 例,单纯机械取栓24 例,桥接治疗76 例.再灌注治疗后结局不良患者69 例(结局不良组),结局良好患者83 例(结局良好组),两组患者年龄、糖尿病、首次发现异常至急诊时间、入院收缩压、入院舒张压、入院NIHSS评分、治疗前D-二聚体、超敏C反应蛋白和NT-proBNP水平差异均有统计学意义(均P<0.05);在CT灌注参数方面,结局不良组具有较大的梗死核心[49(20,84)ml比8(2,19)ml,Z=-7.049,P<0.01]和缺血半暗带体积[164(107,243)ml比55(17,131)ml,Z=-6.128,P<0.01].多因素Logistic回归分析显示,心房颤动相关心源性脑梗死再灌注治疗结局不良的独立影响因素包括入院NIHSS评分(OR =1.203,95%CI:1.085~1.334,P<0.01)、梗死核心体积(OR = 1.048,95%CI:1.023~1.073,P<0.01).联合入院NIHSS评分和梗死核心体积二者的ROC曲线下面积为0.897(P<0.01).结论 心房颤动相关心源性脑梗死再灌注治疗后结局不良的独立影响因素包括入院NIHSS评分和梗死核心体积,联合入院NIHSS评分与梗死核心体积或可对结局不良患者进行有效预测.

Objective Analysis of risk factors influencing poor clinical outcomes of reperfusion therapy for atrial fibrillation-related cardiogenic cerebral infarction.Methods Patients with reperfusion therapy for atrial fibrillation-related cardiogenic cerebral infarction(including intravenous thrombolysis alone,mechanical thrombolysis,and bridging therapy)at the stroke centers of the First Affiliated Hospital of Soochow University and Jiangyin People's Hospital were retrospectively consecutively enrolled from September 2018 to September 2020.Detailed patient data were collected,including gender,age,and history(hypertension,diabetes mellitus,hyperlipidemia,ischemic stroke,coronary artery disease,chronic heart failure,and history of smoking);indicators of admission tests(time from first detection of abnormality to the emergency room,systolic blood pressure,diastolic blood pressure,and the National Institutes of Health stroke scale[NIHSS]score)and pre-treatment laboratory test results(random blood glucose,D-dimer,ultrasensitive C-reactive protein,N-terminal B-type natriuretic peptide proteins[NT-proBNP],and fibrinogen);the site of the responsible vessel(anterior,posterior,and anterior-posterior circulation)was differentiated based on the patient's head-and-neck CT angiography plus CT perfusion imaging,and the relevant imaging parameters(infarct core volume and ischemic semidarkness zone volume)were collected.Time from admission to intravenous thrombolysis was collected in patients treated with intravenous thrombolysis alone and bridging therapy,and time from admission to arterial puncture and revascularization after thrombolysis therapy(modified Thrombolysis in Cerebral Infarction[mTICI]classification)were collected in patients treated with mechanical thrombolysis and bridging.Information of patients at discharge were collected(NIHSS score at discharge).Patients were categorized into poor outcome(mRS score of 3-6)and good outcome(mRS score of 0-2)groups according to their mRS scores at 90 d follow-up after discharge.Factors affecting the outcome after reperfusion therapy for atrial fibrillation-related cardiogenic cerebral infarction were screened by multifactorial Logistic regression analysis,receiver operating characteristic(ROC)curves were generated separately,and the area under the curve was calculated to explore the predictive value for poor outcome.Results A total of 152 patients with reperfusion therapy for atrial fibrillation-associated cardiogenic cerebral infarction were included,including 86 males and 66 females;age ranged from 38 to 91 years,with a mean of(73±10)years.There were 52 cases of intravenous thrombolysis alone,24 cases of mechanical thrombolysis alone,and 76 cases of bridging therapy.There were 69 patients with poor outcome after reperfusion therapy(poor outcome group)and 83 patients with good outcome(good outcome group),and the differences in age,diabetes mellitus,time from first abnormality detection to the emergency room,admission systolic blood pressure,admission diastolic blood pressure,admission NIHSS scores,and pre-treatment levels of D-dimer,ultrasensitive C-reactive protein,and NT-proBNP were statistically significant between the two groups(all P<0.05);in terms of CT perfusion parameters,the poor outcome group had a larger infarct core(49[20,84]ml vs.8[2,19]ml,Z=-7.049,P<0.01)and ischemic penumbra volume(64[107,243]ml vs.55[17,131]ml,Z =-6.128,P<0.01).Multifactorial Logistic regression analysis showed that independent influences on the poor outcome of reperfusion therapy for atrial fibrillation-related cardiogenic cerebral infarction included admission NIHSS score(OR,1.203,95%CI 1.085-1.334,P<0.01),and infarct core volume(OR,1.048,95%CI 1.023-1.073,P<0.01).The area under the ROC curve for the combined admission NIHSS score and infarct core volume was 0.897(P<0.01).Conclusion Independent risk factors affecting poor outcome after reperfusion therapy for atrial fibrillation-associated cardiogenic cerebral infarction include admission NIHSS score and infarct core volume,and the combined admission NIHSS score and infarct core volume can be a useful predictor of patients with poor outcome.

周国庆;朱祖福;王辉;徐裕

214400 江苏省江阴市人民医院神经内科苏州大学附属第一医院神经内科214400 江苏省江阴市人民医院神经外科

心房颤动脑梗死预测结局

Atrial fibrillationCerebral infarctionPredictionOutcome

《中国脑血管病杂志》 2024 (001)

30-37 / 8

江阴市卫生健康委员会科研项目(M202207)

10.3969/j.issn.1672-5921.2024.01.006

评论